细胞因子介导治疗胰腺癌的研究
摘要
胰腺癌是常见的消化道恶性肿瘤之一。目前,胰腺癌的有效治疗方法仍然是以外科手术为主,辅以放化疗的综合治疗。随着免疫和分子生物学在肿瘤发生、发展和转移机制等方面研究的不断深入,细胞因子介导治疗成为治疗胰腺癌的新的发展方向之一。
出处
《中国现代医生》
2009年第17期27-28,共2页
China Modern Doctor
参考文献9
-
1杜光红,李昌平.胰腺癌基因治疗研究进展[J].泸州医学院学报,2008,31(1):104-105. 被引量：1
-
2赵玉沛,戴梦华.胰腺癌生物治疗现状与进展[J].中国普外基础与临床杂志,2002,9(6):371-377. 被引量：5
-
3Sato T, Yamauchi N, Sasaki H, et al. An apoptosis-inducing gene therapy for pancreatic cancer with combination of 55-KDa tumor necrosis factor (TNF)receptor gene transfection and mutein TNF administration[J]. Cancer Res, 1995;58: 1677.
-
4O'donnell,Michael A,Luo,et al. Interleukin 12 immunotherapy of murine transitional cell carcinoma of the bladder:dose dependent tumor eradication and generation of protective immunity[J]. J Urol,2004, 171 (3):1330.
-
5Yang,James C, Sherry, et al. Randomized study of high dose and low dose interleukin 2 in patients with metastatic renal cancer[J]. J Clin Oncol, 2003,21(16):3127.
-
6Younes,Anas,Kadin,Marshall E. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy[J]. J Clin Oncol, 2003,21( 18 ) : 3526.
-
7Misawa,Eriko,Sakurai,et al. Booster effect of interleukin 2 on natural killer 1 1+cells stimulated by administration of macrophage colong stimulaling factor in mice[J]. J Immunother,2003,26( 1 ) :21.
-
8Gjertsen MK. Intradermal ras peptide vaccination with granulocyto macrophage ecolonestimulating factor as adjuvant: clinical and immunological responses in patients with pancreat adeno carcinoma [J]. Int J Cancer, 2001,92( 3 ) : 441-450.
-
9Yamada,Hiroshi,Matsumoto,et al. Murine IL 2 Secreting recombinant bacillus calmette guerin augments macrophage mediated c~lotoxicity against muring bladder cancer MBT 2[J]. Urol, 2003,164(2 ):526.
二级参考文献22
-
1冯燮林,张肇达,田聆,魏于全.腺病毒介导的DPC4基因转染对胰腺癌细胞的影响[J].四川大学学报（医学版）,2004,35(5):607-611. 被引量：4
-
2[1]Schreiber M, Muller WJ, Singh G, et al. Comparision of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4a, p18INK4C , p19INK4D, p21WAF1/CIPI and p27KIPI in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity [J].Oncogene, 1999; 18(9): 1663
-
3[2]ChintalaSK,FueyoJ, Gomez-ManzanoC, etal. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro [J]. Oncogene, 1997; 15(17):2049
-
4[3]Fujimoto K, Hosotani R, Miyamoto Y, et al. Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16 (INK4A) fusion peptide in pancreatic cancer cells [J]. Cancer Lett, 2000; 159(2): 151
-
5[4]Ghaneh P, Greenhalf W, Humpreys M, et al. Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo [J]. Gene Ther, 2001; 8(3): 199
-
6[5]Bouvet M, Bold RJ, Lee J, et al. Adenovirus-mediated wild-type p53 tumor suppresser gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [J]. Ann Surg Onco, 1998;5(8): 681
-
7[6]Fujiwara T, Grimm EA, Mukhopadhyay T, et al. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirusmediated transfer of the wild-type p53 gene [J]. Cancer Res,1994; 54(9): 2287
-
8[7]Yang L, Hwang R, Pandit L, et al. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir [J]. AnnSurg, 1996; 224(3):405
-
9[8]Alpaugh RK, Schultz J, McAleer C, et al. Superantigen-targeted therapy: phase I escalating repeat dose trial of the fusion protein PNU-214565 in patients with advanced gastrointestinal malignancies [J]. Clin Cancer Res, 1998; 4(8): 1903
-
10[9]Schmiegel W, Schmielau J, Henne-Bruns D, et al. Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer [J]. Proc Natl Acad Sci USA, 1997; 94(23): 12622
共引文献4
-
1张树华,熊炯炘,杨智勇,王春友.胰腺正常组织、癌组织及癌旁组织LDH活性及其同工酶谱分析[J].中国普外基础与临床杂志,2009,16(2):129-132. 被引量：5
-
2张太平,杜潇,赵玉沛.多学科综合治疗胰腺癌现状及评价[J].中国实用外科杂志,2009,29(9):771-773. 被引量：20
-
3徐云柯,苏松,淦宇,方程,彭方毅,李波.胰腺全系膜切除的胰十二指肠切除术治疗壶腹周围癌及胰头癌的安全性及疗效分析[J].中国普外基础与临床杂志,2018,25(12):1464-1468. 被引量：4
-
4秦仁义,陈立模.胰腺癌的综合治疗[J].中国实用外科杂志,2004,24(5):306-309. 被引量：2
-
1血管瘤[J].医食参考,2010(2):27-27.
-
2胡娟,孙金和,胡静.彩超在肝血管瘤微介导治疗中的引导技术[J].中国社区医师（医学专业）,2012,14(25):221-222. 被引量：1
-
3焦保华,代彬,姚志刚.脑胶质瘤中P33^(ING1)的表达及临床意义[J].中国神经精神疾病杂志,2007,33(5):304-306.
-
4胡云洲,邓侯富.放射性药物介导治疗骨转移癌[J].四川医学,1995,16(3):134-135.
-
5程文,荆慧,郭文佳,汤丽丽.超声介导治疗宫颈癌术后淋巴囊肿[J].哈尔滨医科大学学报,2009,43(4):412-413. 被引量：7
-
6杨映红,林礼务,杨发端,高尚达,林秀芳,何以敉.超声介导瘤内注射“99-star”治疗人肝癌smmc-7721裸鼠模型中Bcl-2蛋白表达[J].福建医药杂志,2001,23(6):110-111.
-
7邓敬兰.肿瘤生长抑素受体亚型的分布与表达[J].国外医学（放射医学核医学分册）,1997,21(5):256-261. 被引量：2
-
8曾凡军,周媛媛,宋新宇,熊晓琦,赵必君,陈世雄.β-连环蛋白与抑癌基因ING1蛋白在肺癌组织中的表达[J].疑难病杂志,2012,11(2):110-112. 被引量：1
-
9项明,朱上林,吴达明,谢弘.单克隆抗体导向治疗中、晚期肝癌的观察[J].外科,1997,2(1):34-36.
-
10杨映红,林礼务,杨发端,林秀芳,高上达.肝肿瘤细胞学检查动态观察评估介入治疗效果[J].福建医药杂志,2001,23(5):28-29.
